Reuters
23 Sept 2026, 04:13 UTC · 14h ago
Novo Nordisk open to New York listing upgrade, CEO Doustdar tells FT
Verdict
Headline takes no side. One claim, scored +0.30 — moderately bullish.
- NIS score · 1 claim
+0.30moderately bullish
−1 bearish0bullish +1More positive than 63% of claims this week
Scored by the NIS engine · methodology.

